Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP2 | O95551 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | ALPL | P05186 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29958253 | 0.80 | TDP2 (0.50) | TDP2ALDH1A1MAPTL3MBTL1KDM4E | |
| SCHEMBL28890594 | 0.80 | TDP2 (0.50) | TDP2ALDH1A1MAPTL3MBTL1KDM4E | |
| SCHEMBL9201592 | 0.80 | TDP2 (0.50) | TDP2ALDH1A1MAPTL3MBTL1KDM4E | |
| SCHEMBL13295304 | 0.77 | TDP2 (0.49) | TDP2ALDH1A1MAPTL3MBTL1KDM4E | |
| SCHEMBL9203839 | 0.76 | TDP2 (0.43) | TDP2ALDH1A1MAPTL3MBTL1KDM4E | |
| SCHEMBL9203313 | 0.74 | TDP2 (0.46) | TDP2ALDH1A1MAPTL3MBTL1KDM4E | |
| SCHEMBL28087596 | 0.74 | ALDH1A1 (0.56) | TDP2ALDH1A1MAPTL3MBTL1KDM4E | |
| SCHEMBL14248069 | 0.74 | LMNA (0.40) | TDP2ALDH1A1MAPTL3MBTL1KDM4E | |
| SCHEMBL9204538 | 0.71 | TDP2 (0.46) | TDP2ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL9202279 | 0.71 | GSK3B (0.48) | TDP2MAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10150736-B2 | Haptens and immunoreactive agents and use thereof for producing family antibodies and immunoassays for quinolones | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (ES) | 2018-12-11 | — | — | US | disclosed |
| US-20130273581-A1 | HAPTENS AND IMMUNOREACTIVE AGENTS AND USE THEREOF FOR PRODUCING FAMILY ANTIBODIES AND IMMUNOASSAYS FOR QUINOLONES | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (ES) | 2013-10-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130273581-A1 | HAPTENS AND IMMUNOREACTIVE AGENTS AND USE THEREOF FOR PRODUCING FAMILY ANTIBODIES AND IMMUNOASSAYS FOR QUINOLONES | NQO2, NISCH, VIP | TDP2 4424/4885ALDH1A1 2214/4885MAPT 4204/4885 |
| US-10150736-B2 | Haptens and immunoreactive agents and use thereof for producing family antibodies and immunoassays for quinolones | NQO2, NISCH, VIP | TDP2 4424/4885ALDH1A1 2214/4885MAPT 4204/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.